We launched two key innovations in the U.S. to help improve outcomes for cardiac patients at the American College of Cardiology Conference💓 💜 Flyrcado™ is a first-of-its-kind unit dose ...

CardioVia announced Tuesday it received Food and Drug Administration clearance for its ViaOne device that can access the heart’s surface to diagnose and treat cardiac conditions without using an ...

GE HealthCare (Nasdaq: NASDAQ:GEHC) today announced that the U.S. Food and Drug Administration (FDA) has granted approval of ...

In a challenging market environment, GE Healthcare Holding LLC (NASDAQ:GEHC) stock has touched a 52-week low, reaching a price... ByInvesting.com • Apr 03, 2025 GE HealthCare Completes Acquisition of ...